Cue Biopharma (CUE) Financials: Revenue & Earnings

CUE price $21.20 +2.88 +15.72%

Ticker
CUE
Price
$21.20
Change
+2.88 +15.72%
Market cap ?
$154.01M
P/E ?
-0.69
Dividend yield ?
0.00%
Beta ?
2.63
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
001142604345833131543251494137012450005490000928700027466000

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical enterprise focused on creating biological therapies. Its central objective is the precise manipulation of the human immune system to address a spectrum of severe conditions, such as various cancers, chronic infectious diseases, and autoimmune disorders. The company's leading investigational therapeutic is CUE-101, a specialized fusion protein biologic. This…

Fair value

CUE fair value Not meaningful. Price $21.20.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare CUE

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-11—-2.24—1.03M
2026-08-14-24.14-1.697.88M3.00M
2026-05-14-1.08-3.305.69M2.50M
2026-03-160.30-2.7021.94M1.00M
2025-11-12-2.10-2.802.15M2.29M
2025-08-12-2.70-3.902.95M2.00M
2025-05-12-5.11-4.20421.00K1.27M
2025-03-31-3.90-2.581.58M1.70M
2024-11-14-5.11-5.473.34M1.52M
2024-08-19-6.01-0.292.66M1.29M
2024-05-09-7.51-8.461.72M1.21M
2024-04-08-0.29-0.281.82M966.67K
2023-11-09-7.21-0.332.10M1.31M
2023-08-09-8.71-0.301.38M907.50K
2023-05-09-0.29-0.29187.00K1.95M
2023-03-21-11.11-0.29151.00K103.75K
2022-11-14-0.31-0.3868.00K513.50K
2022-08-04-0.37-0.4226.00K1.13M
2022-05-10-13.21-0.431.00M3.05M
2022-03-16-7.81-0.428.25M1.14M
2021-11-09-12.31-11.712.40M2.05M
2021-08-09-9.91-12.612.74M2.74M
2021-05-17-12.31-11.111.55M1.43M
2021-03-16-11.11-0.35475.32K1.49M
2020-11-17-10.21-11.11704.00K1.27M
2020-08-07-11.41-0.431.07M1.22M
2020-05-07-14.41-0.35900.00K656.25K
2020-03-12-11.11-0.451.05M1.31M
2019-11-07-9.31-0.44984.00K1.40M
2019-08-08-13.81-16.821.05M1.28M
2019-05-08-16.22-0.40370.00K274.07K
2019-03-14-17.42-0.40330.60K228.00K
2018-11-13-18.62-11.41449.00K275.19K
2018-08-13-10.81—172.00K—
2018-05-14-11.10———
2018-03-29-15.30———
2017-09-30-0.24———
2017-06-30-0.21———
2017-03-31-0.16———
2016-12-31-0.14———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-10-12Ray SumitaSell1.84K$28.0551.72K
2026-10-12Meluzio Michael VincentSell1.14K$28.0532.09K
2026-10-12Lin Shao-LeeSell10.00K$27.50275.00K
2026-10-12Lin Shao-LeeSell1.09K$28.0530.49K
2026-08-13Ray SumitaBuy18.20K——
2026-08-13Ray SumitaSell2.38K$29.3769.99K
2026-08-13Ray SumitaSell6.44K$30.35195.51K
2026-08-13Ray SumitaSell4$31.13125
2026-08-13Ray SumitaSell18.20K——
2026-08-13Meluzio Michael VincentBuy13.65K——
2026-08-13Meluzio Michael VincentSell1.52K$29.3744.61K
2026-08-13Meluzio Michael VincentSell4.11K$30.35124.62K
2026-08-13Meluzio Michael VincentSell3$31.1393
2026-08-13Meluzio Michael VincentSell13.65K——
2026-08-13Lin Shao-LeeSell5.42K$27.19147.45K
2026-08-13Lin Shao-LeeSell2.38K$28.1166.76K
2026-08-13Lin Shao-LeeSell10.46K$29.48308.36K
2026-08-12Lin Shao-LeeBuy109.18K——
2026-08-12Lin Shao-LeeSell34.23K$26.99923.73K
2026-08-12Lin Shao-LeeSell5.78K$27.75160.26K
2026-08-12Lin Shao-LeeSell109.18K——
2026-07-30Ahlers James MBuy51.00K$30.401.55M
2026-07-30Ahlers James MBuy25.50K——
2026-07-30Ahlers James MOther0——
2026-07-13Borie Dominique ChristianBuy63.00K$30.921.95M
2026-07-13Borie Dominique ChristianBuy31.50K——
2026-07-13Borie Dominique ChristianOther0——
2026-07-09Sarraf PashaBuy18.40K——
2026-07-09Garzone PamelaBuy18.90K——
2026-07-09Garzone PamelaBuy21.80K——
2026-07-09Camardo Daniel A.Buy21.80K——
2026-07-09Sarraf PashaBuy21.80K——
2026-07-09Meehan Viola MongBuy21.80K——
2026-07-09Meluzio Michael VincentBuy40.94K——
2026-07-09Ray SumitaBuy54.59K——
2026-07-09Ray SumitaBuy54.59K——
2026-07-09Lin Shao-LeeBuy327.54K——
2026-07-09Lin Shao-LeeBuy327.54K——
2026-06-01Lin Shao-LeeBuy90.91K$0.0091
2026-06-01Lin Shao-LeeBuy45.45K$11.00499.98K
2026-06-01Meluzio Michael VincentOther0——
2026-06-01Ray SumitaOther0——
2026-06-01Ray SumitaOther109.18K$30.423.32M
2026-06-01Lin Shao-LeeBuy90.91K$0.0091
2026-06-01Lin Shao-LeeBuy45.45K$11.00499.98K
2026-05-30Camardo Daniel A.Buy1.63K$21.9035.61K
2026-05-30Camardo Daniel A.Other0——
2026-05-30Meehan Viola MongBuy1.63K$21.9035.61K
2026-05-30Meehan Viola MongOther0——
2026-05-03Lin Shao-LeeBuy655.07K$30.4219.93M
2026-05-03Lin Shao-LeeBuy327.54K——
2026-04-30Lin Shao-LeeOther0——
2026-04-09Sandercock ColinBuy200.00K$0.2958.00K
2026-04-09Warren LucindaBuy250.00K$0.2972.50K
2026-04-09Baker Daniel G.Buy100.00K$0.2929.00K
2026-01-02Kiener Peter ABuy24.40K$0.348.30K
2026-01-02Broadfoot Jill MarieBuy24.40K$0.348.30K
2026-01-02Garzone PamelaBuy24.40K$0.348.30K
2026-01-02Morich FrankBuy24.40K$0.348.30K
2026-01-02Verheyen PatrickBuy24.40K$0.348.30K
2026-01-02Sarraf PashaBuy24.40K$0.348.30K
2025-12-30Sarraf PashaBuy77.42K$0.3023.35K
2025-12-30Sarraf PashaBuy78.12K$0.3124.33K
2025-12-30Sarraf PashaBuy86.95K$0.3227.60K
2025-12-30Sarraf PashaBuy77.15K$0.3023.17K
2025-12-30Sarraf PashaBuy4.23K$0.311.31K
2025-12-03Sandercock ColinBuy70.00K$0.7049.00K
2025-09-29Warren LucindaBuy125.00K$0.7290.00K
2025-09-29Baker Daniel G.Buy50.00K$0.7236.00K
2025-09-29Azam UsmanBuy1.88M$0.721.35M
2025-09-29Azam UsmanOther0——
2025-09-26Sandercock ColinBuy30.00K$0.7021.00K
2025-06-04Broadfoot Jill MarieBuy48.80K$0.6230.26K
2025-06-04Broadfoot Jill MarieOther0——
2025-03-21Millar Kerri-AnnBuy200.00K$0.99198.00K
2025-03-21PASSERI DANIEL RBuy450.00K$0.99445.50K
2025-03-21Baker Daniel G.Buy100.00K$0.9999.00K
2025-03-21Sandercock ColinBuy200.00K$0.99198.00K
2025-03-21Warren LucindaBuy250.00K$0.99247.50K
2025-03-21Levisetti MatteoBuy250.00K$0.99247.50K
2025-03-10Sarraf PashaBuy48.80K$1.0350.26K
2025-03-10Sarraf PashaOther0——
2025-01-02Verheyen PatrickBuy24.40K$1.0926.60K
2025-01-02Garzone PamelaBuy24.40K$1.0926.60K
2025-01-02Morich FrankBuy24.40K$1.0926.60K
2025-01-02DRISCOLL FREDERICK WBuy24.40K$1.0926.60K
2025-01-02Kiener Peter ABuy24.40K$1.0926.60K
2024-12-16PASSERI DANIEL RBuy30.00K$1.0330.90K
2024-11-25Baker Daniel G.Buy200.00K$1.06212.00K
2024-11-25Baker Daniel G.Other0——
2024-09-03Warren LucindaOther0——
2024-09-03Warren LucindaBuy350.00K$0.66231.00K
2024-06-05Levisetti MatteoBuy125.00K$1.65206.25K
2024-06-05Suri AnishBuy150.00K$1.65247.50K
2024-06-05Fox Michael JBuy48.80K$1.6580.52K
2024-06-05Sandercock ColinBuy60.00K$1.6599.00K
2024-06-05Fox Michael JOther0——
2024-06-05Fox Michael JOther0——
2024-06-05Millar Kerri-AnnBuy60.00K$1.6599.00K
2024-03-06Sandercock ColinBuy175.00K$1.94339.50K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 52, holders -3 vs prior quarter. Ownership 34.44%.

HolderSharesChangeChange %Value
BLEICHROEDER LP370.68K-6.45M-94.56%11.70M
DRIEHAUS CAPITAL MANAGEMENT LLC292.14K292.14KNew9.22M
VANGUARD CAPITAL MANAGEMENT LLC161.70K-2.30M-93.42%5.10M
IKARIAN CAPITAL, LLC104.36K104.36KNew3.29M
TETRAGON PARTNERS GP LTD93.82K93.82KNew2.96M
STEMPOINT CAPITAL LP67.00K67.00KNew2.11M
BLACKROCK, INC.57.81K-391.35K-87.13%1.82M
ADAR1 CAPITAL MANAGEMENT, LLC55.19K55.19KNew1.74M
LION POINT CAPITAL, LP52.93K-2.15M-97.60%1.67M
SQUADRON CAPITAL MANAGEMENT LLC50.00K50.00KNew1.58M
DIADEMA PARTNERS LP48.37K-83.63K-63.36%1.53M
GEODE CAPITAL MANAGEMENT, LLC47.82K-1.02M-95.51%1.51M
BOOTHBAY FUND MANAGEMENT, LLC31.46K31.46KNew992.85K
UBS GROUP AG26.70K-61.65K-69.78%842.65K
CITADEL ADVISORS LLC25.63K12.93K+101.83%808.98K
VANGUARD FIDUCIARY TRUST CO24.48K-519.11K-95.50%772.46K
TEXAS CAPITAL BANK WEALTH MANAGEMENT SERVICES INC22.88K-374.54K-94.24%722.12K
RENAISSANCE TECHNOLOGIES LLC14.69K-199.14K-93.13%463.58K
STATE STREET CORP14.18K-165.18K-92.10%447.39K
PERSISTENT ASSET PARTNERS LTD12.33K-21.04K-63.04%389.20K
ROBERTSON STEPHENS WEALTH MANAGEMENT, LLC11.13K-467.37K-97.67%351.36K
SUSQUEHANNA INTERNATIONAL GROUP, LLP11.00K-13.61K-55.30%347.25K
SEVEN FLEET CAPITAL MANAGEMENT LP10.70K10.70KNew337.75K
SUSQUEHANNA INTERNATIONAL GROUP, LLP10.00K-14.61K-59.37%315.60K
NORTHERN TRUST CORP9.12K-85.48K-90.36%287.89K

Earnings and financials

Cue Biopharma, Inc. (CUE) trades at $21.20, with a market cap of $154.01M and a trailing P/E of -0.69. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
001142604345833131543251494137012450005490000928700027466000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Cue Biopharma (CUE) Financials: Revenue & Earnings

CUE$21.20+2.88 +15.72%

$154.01M

Market Cap

-0.69

P/E

—

Forward P/E

—

Score

Price History